RICHMOND, Va. - A federal appeals panel on Jan. 28 affirmed summary judgment in a metoclopramide generic drug injury case, finding that the plaintiff's claims are preempted by federal law or that the plaintiff failed to properly amend her complaint to add a claim that may not be preempted (Arthur L. Drager, et al. v. Pliva USA, Inc., et al., No. 12-1259, 4th Cir.; 2014 U.S. App. LEXIS 1696).